tiprankstipranks
Trending News
More News >
Shanghai Pioneer Holding Ltd (HK:1345)
:1345
Hong Kong Market
Advertisement

Shanghai Pioneer Holding Ltd (1345) AI Stock Analysis

Compare
0 Followers

Top Page

HK:1345

Shanghai Pioneer Holding Ltd

(1345)

Rating:61Neutral
Price Target:
HK$2.00
â–¼(-1.48% Downside)
Shanghai Pioneer Holding Ltd's strong financial health and attractive dividend yield are offset by bearish technical indicators. The stock's valuation is reasonable, but the current market momentum suggests caution.

Shanghai Pioneer Holding Ltd (1345) vs. iShares MSCI Hong Kong ETF (EWH)

Shanghai Pioneer Holding Ltd Business Overview & Revenue Model

Company DescriptionChina Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas, as well as medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company sells its products to hospitals and medical institutions, and pharmacies. It also sells ancillary tools and leases accessories; and sells dental devices. In addition, the company engages in the sale of imported in-licensed prescription products. China Pioneer Pharma Holdings Limited was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. China Pioneer Pharma Holdings Limited is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.
How the Company Makes MoneyShanghai Pioneer Holding Ltd makes money through two primary revenue streams: sales of developed properties and property management services. The company generates significant revenue from selling residential and commercial units within its developed projects. Additionally, it earns recurring income by offering property management services, which include maintenance, security, and facility management for its developed properties. The company's earnings are influenced by the real estate market conditions in China and its ability to successfully complete and sell its development projects.

Shanghai Pioneer Holding Ltd Financial Statement Overview

Summary
Shanghai Pioneer Holding Ltd demonstrates strong financial health with a robust balance sheet and efficient cost management. However, variability in profitability and cash flow slightly dampens the overall financial performance score.
Income Statement
75
Positive
Shanghai Pioneer Holding Ltd shows a consistent revenue base with moderate growth. The gross profit margin is healthy, reflecting efficient cost management. However, the net profit margin has fluctuated, indicating some instability in profitability. The EBIT and EBITDA margins are stable, suggesting solid operational efficiency.
Balance Sheet
78
Positive
The balance sheet is robust, with a low debt-to-equity ratio signifying strong financial health and low leverage. The return on equity indicates efficient use of shareholders’ funds, although there is room for improvement. The equity ratio demonstrates a stable capital structure, providing a solid foundation for future growth.
Cash Flow
70
Positive
The company has shown strong free cash flow growth, rebounding from previous negative figures, which supports operational investments and reduces financial risk. The operating cash flow to net income ratio is positive, indicating good cash conversion. However, fluctuations in free cash flow to net income ratio suggest potential variability in cash generation.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.53B1.57B1.56B1.43B1.33B
Gross Profit683.21M668.24M780.47M772.03M607.97M
EBITDA215.27M201.88M245.38M199.96M104.79M
Net Income151.62M145.72M235.30M142.63M52.45M
Balance Sheet
Total Assets1.46B1.53B1.57B1.33B1.43B
Cash, Cash Equivalents and Short-Term Investments103.57M124.43M289.01M402.08M254.61M
Total Debt75.22M74.02M37.59M14.05M15.10M
Total Liabilities342.52M513.14M549.18M417.49M516.73M
Stockholders Equity1.11B1.01B1.01B907.97M909.43M
Cash Flow
Free Cash Flow208.01M-163.24M19.02M225.43M39.37M
Operating Cash Flow214.83M-118.69M93.30M242.06M74.24M
Investing Cash Flow-99.76M69.51M-12.99M8.39M23.93M
Financing Cash Flow-125.92M-50.56M-91.03M-140.28M-253.04M

Shanghai Pioneer Holding Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.03
Price Trends
50DMA
2.17
Negative
100DMA
2.16
Negative
200DMA
2.18
Negative
Market Momentum
MACD
-0.03
Positive
RSI
30.44
Neutral
STOCH
66.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1345, the sentiment is Negative. The current price of 2.03 is below the 20-day moving average (MA) of 2.17, below the 50-day MA of 2.17, and below the 200-day MA of 2.18, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 30.44 is Neutral, neither overbought nor oversold. The STOCH value of 66.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1345.

Shanghai Pioneer Holding Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (46)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$2.18B10.048.35%8.25%0.61%-15.89%
73
Outperform
HK$1.97B3.2218.33%5.70%-9.95%67.56%
67
Neutral
HK$2.81B9.7712.47%4.03%7.43%21.88%
63
Neutral
HK$376.03M7.936.61%5.11%-3.59%4.81%
61
Neutral
HK$2.59B15.3014.36%5.20%-4.04%2.92%
46
Neutral
C$209.14M-0.30-24.12%3.18%19.38%-2.35%
45
Neutral
HK$303.96M80.950.64%20.59%-26.91%-98.72%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1345
Shanghai Pioneer Holding Ltd
2.03
0.07
3.57%
HK:1110
Kingworld Medicines Group Ltd.
0.62
0.14
29.17%
HK:2219
Chaoju Eye Care Holdings Ltd.
3.03
0.39
14.77%
HK:2348
Dawnrays Pharmaceutical Holdings Ltd.
1.30
0.28
27.45%
HK:2633
Jacobson Pharma Corporation Limited
1.51
1.01
202.00%
HK:3390
Tycoon Group Holdings Limited
0.33
-3.45
-91.27%

Shanghai Pioneer Holding Ltd Corporate Events

Shanghai Pioneer Holding Ltd Issues Profit Warning Amid Reduced Government Grants
Aug 12, 2025

Shanghai Pioneer Holding Ltd has issued a profit warning, indicating a significant decrease in net profit by approximately 45% to 48% for the first half of 2025 compared to the same period last year. This decline is attributed mainly to a substantial reduction in government grants received, exceeding RMB30.0 million. The announcement is based on preliminary unaudited financial assessments, and the final results will be disclosed at the end of August 2025. Stakeholders are advised to exercise caution when dealing with the company’s securities.

Shanghai Pioneer Holding Ltd Updates Nomination Committee
Jun 30, 2025

Shanghai Pioneer Holding Ltd has announced changes in the composition of its nomination committee, appointing Ms. Hu Mingfei and Mr. Zhang Changhai as new members. This move aligns with the upcoming amendments to the Listing Rules and Corporate Governance Code, effective July 1, 2025, and aims to enhance board effectiveness, diversity, and overall corporate governance.

Shanghai Pioneer Holding Ltd Announces Board Restructuring
Jun 30, 2025

Shanghai Pioneer Holding Ltd has announced changes to its board of directors, effective from June 30, 2025. The update includes the appointment of Mr. Li Xinzhou as Chairman, with Mr. Yang Yuewen and Mr. Zhang Quan as executive directors, Ms. Hu Mingfei as a non-executive director, and Mr. Zhang Hong, Mr. Lai Chanshu, and Mr. Zhang Changhai as independent non-executive directors. These changes are expected to influence the company’s governance and strategic direction, potentially impacting its market positioning and stakeholder relations.

Shanghai Pioneer Holding Ltd Updates Nomination Committee Terms
Jun 30, 2025

Shanghai Pioneer Holding Ltd has announced the amendment of the terms of reference for its Nomination Committee, effective from June 30, 2025. The committee is tasked with identifying and recommending candidates for the board of directors, ensuring diversity and independence in its composition, and meeting at least annually to fulfill its responsibilities. This move is expected to enhance the governance and operational efficiency of the company, aligning with the listing rules of the Hong Kong Stock Exchange and potentially strengthening its market position.

Shanghai Pioneer Holding Ltd AGM: All Resolutions Passed, Dividend Declared
May 30, 2025

Shanghai Pioneer Holding Ltd successfully conducted its Annual General Meeting on May 30, 2025, where all proposed resolutions were passed. Key resolutions included the re-election of directors, the authorization for the board to fix directors’ remuneration, the reappointment of BDO Limited as auditor, and the approval of a general mandate for share allotment and repurchase. The company also declared a final dividend, indicating a stable financial position and continued shareholder value focus.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 21, 2025